BioCentury
ARTICLE | Clinical News

Fazaclo clozapine regulatory update

March 15, 2004 8:00 AM UTC

CIMA said the FDA approved Alamo's Fazaclo to treat severe schizophrenia in patients who fail to respond to standard drug treatment. CIMA will manufacture the orally disintegrating tablet formulation ...